![Gregory B. Holmes](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Gregory B.
Holmes joined SFBC International, Inc. as Executive Vice President-Clinical Operations in February 1999.
He is Executive Vice President-Clinical Operations for Pharmanet Development Group, Inc. From January 1997 to February 1999, he was President of Clinical Research for Phoenix International Life Sciences, Inc.
Former positions of Gregory B. Holmes
Companies | Position | End |
---|---|---|
Phoenix International Life Sciences, Inc.
![]() Phoenix International Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sotera Health Co., Phoenix International Life Sciences, Inc. is a Canadian company that provides bioanalytical research and clinical testing services. The company is based in Saint-Laurent, Canada. Phoenix International Life Sciences was acquired by Nordion (Canada), Inc., part of Sotera Health Co. from July 30, 2018 on May 22, 2000 for $236.74 million. | Corporate Officer/Principal | 31/01/1999 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Phoenix International Life Sciences, Inc.
![]() Phoenix International Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sotera Health Co., Phoenix International Life Sciences, Inc. is a Canadian company that provides bioanalytical research and clinical testing services. The company is based in Saint-Laurent, Canada. Phoenix International Life Sciences was acquired by Nordion (Canada), Inc., part of Sotera Health Co. from July 30, 2018 on May 22, 2000 for $236.74 million. | Commercial Services |
- Stock Market
- Insiders
- Gregory B. Holmes